Business, Technology

vSMP MemoryONE attains VMware Partner Ready for vSphere validation

FORT LEE, N.J. — (BUSINESS WIRE) — #ESXi–ScaleMP™, a leading provider of virtualization for high-end computing, today announced that its vSMP MemoryONE has attained VMware Partner Ready for vSphere validation. By validating vSMP MemoryONE 10.0 with VMware vSphere® 7.0, and attaining the

Business, Health Care

European Commission approves KEYTRUDA® (pembrolizumab) as first-line treatment in adult patients with metastatic microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) colorectal cancer

KEYTRUDA Is First Checkpoint Inhibitor Approved in Europe to Treat MSI-H or dMMR Colorectal Cancer European Approval Based on Results From KEYNOTE-177 Trial Demonstrating KEYTRUDA Significantly Reduced Risk of Disease Progression or Death by 40% Compared With Chemotherapy KENILWORTH, N.J. — (BUSINESS